L. Bufalino

778 total citations
22 papers, 613 citations indexed

About

L. Bufalino is a scholar working on Genetics, Orthopedics and Sports Medicine and Molecular Biology. According to data from OpenAlex, L. Bufalino has authored 22 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 10 papers in Orthopedics and Sports Medicine and 8 papers in Molecular Biology. Recurrent topics in L. Bufalino's work include Estrogen and related hormone effects (11 papers), Bone health and osteoporosis research (10 papers) and Bone Metabolism and Diseases (7 papers). L. Bufalino is often cited by papers focused on Estrogen and related hormone effects (11 papers), Bone health and osteoporosis research (10 papers) and Bone Metabolism and Diseases (7 papers). L. Bufalino collaborates with scholars based in Italy, France and United States. L. Bufalino's co-authors include D. Agnusdei, C. Gennari, S. Ortolani, Gaetano Crepaldi, Maria Luisa Brandi, Laura Masi, M Passeri, Giancarlo Isaia, P. Ballanti and E. Bonucci and has published in prestigious journals such as Journal of Bone and Mineral Research, Osteoporosis International and Calcified Tissue International.

In The Last Decade

L. Bufalino

20 papers receiving 555 citations

Peers

L. Bufalino
L. Bufalino
Citations per year, relative to L. Bufalino L. Bufalino (= 1×) peers Leszek Śliwiński

Countries citing papers authored by L. Bufalino

Since Specialization
Citations

This map shows the geographic impact of L. Bufalino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Bufalino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Bufalino more than expected).

Fields of papers citing papers by L. Bufalino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Bufalino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Bufalino. The network helps show where L. Bufalino may publish in the future.

Co-authorship network of co-authors of L. Bufalino

This figure shows the co-authorship network connecting the top 25 collaborators of L. Bufalino. A scholar is included among the top collaborators of L. Bufalino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Bufalino. L. Bufalino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gennari, C., S. Adámi, D. Agnusdei, et al.. (1997). Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass. Calcified Tissue International. 61(S1). S19–S22. 35 indexed citations
2.
Agnusdei, D. & L. Bufalino. (1997). Efficacy of ipriflavone in established osteoporosis and long-term safety. Calcified Tissue International. 61(S1). S23–S27. 35 indexed citations
3.
Reginster, Jean‐Yves, L. Bufalino, Claus Christiansen, et al.. (1997). Design for an ipriflavone multicenter European fracture study. Calcified Tissue International. 61(S1). S28–S32. 5 indexed citations
4.
Agnusdei, D., Gaetano Crepaldi, Giancarlo Isaia, et al.. (1997). A Double Blind, Placebo-Controlled Trial of Ipriflavone for Prevention of Postmenopausal Spinal Bone Loss. Calcified Tissue International. 61(2). 142–147. 44 indexed citations
5.
Adámi, S., L. Bufalino, Ombretta Di Munno, et al.. (1997). Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over 2 years. Osteoporosis International. 7(2). 119–125. 40 indexed citations
6.
Ghezzo, C., Roberto Civitelli, Sandrine Cadel, et al.. (1996). Ipriflavone does not alter bone apatite crystal structure in adult male rats. Calcified Tissue International. 59(6). 496–499. 9 indexed citations
7.
Agnusdei, D., C. Gennari, & L. Bufalino. (1995). Prevention of early postmenopausal bone loss using low doses of conjugated estrogens and the non-hormonal, bone-active drug ipriflavone. Osteoporosis International. 5(6). 462–466. 40 indexed citations
8.
Valente, Michele, et al.. (1994). Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass. Calcified Tissue International. 54(5). 377–380. 62 indexed citations
9.
Bonucci, E., et al.. (1992). Ipriflavone inhibits osteoclast differentiation in parathyroid transplanted parietal bone of rats. Calcified Tissue International. 50(4). 314–319. 51 indexed citations
10.
Bonucci, E., G. Silvestrini, P. Ballanti, et al.. (1992). Cytological and ultrastructural investigation on osteoblastic and preosteoclastic cells grown in vitro in the presence of ipriflavone: Preliminary results. Bone and Mineral. 19. S15–S25. 23 indexed citations
11.
Passeri, M, et al.. (1992). Effect of ipriflavone on bone mass in elderly osteoporotic women. Bone and Mineral. 19. S57–S62. 29 indexed citations
12.
Santucci, Luca, et al.. (1992). Placebo-controlled comparison of piroxicam-?-cyclodextrin, piroxicam, and indomethacin on gastric potential difference and mucosal injury in humans. Digestive Diseases and Sciences. 37(12). 1825–1832. 14 indexed citations
13.
Melis, Gian Benedetto, Anna Maria Paoletti, Angelo Cagnacci, et al.. (1992). Lack of any estrogenic effect of ipriflavone in postmenopausal women. Journal of Endocrinological Investigation. 15(10). 755–761. 32 indexed citations
14.
Benvenuti, Susanna, Annalisa Tanini, Laura Masi, et al.. (1991). Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line. Journal of Bone and Mineral Research. 6(9). 987–996. 92 indexed citations
15.
Santucci, Luca, Stefano Fiorucci, L. Patoia, et al.. (1990). Gastric Tolerance of Piroxicam-β-Cyclodextrin Compared with Placebo and with Other NSAIDs. Clinical Drug Investigation. 2(S4). 56–60. 6 indexed citations
16.
Avogaro, P, et al.. (1989). A cross-over controlled study on beclobrate versus bezafibrate in the treatment of type IIb hyperlipoproteinaemia.. PubMed. 15(6-7). 325–33. 1 indexed citations
17.
Patoia, L., et al.. (1989). Comparison of faecal blood loss, upper gastrointestinal mucosal integrity and symptoms after piroxicam beta-cyclodextrin, piroxicam and placebo administration. European Journal of Clinical Pharmacology. 36(6). 599–604. 21 indexed citations
18.
Acerbi, Daniela, et al.. (1988). Pharmacokinetic study on piroxicam at the steady-state in elderly subjects and younger adults after administration of piroxicam beta-cyclodextrin.. PubMed. 8(3). 175–80. 7 indexed citations
19.
Bufalino, L., et al.. (1986). Treatment of acute pain of ureteral and biliary colic with naproxen sodium administered by the parenteral route.. PubMed. 6(6). 495–500. 6 indexed citations
20.
Bufalino, L., et al.. (1974). [Study of the stability and biologic availability of a sulfomucopolysaccharide administered orally].. PubMed. 29(5). 264–71. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026